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EFFECTS OF STORAGE 
TEMPERATURE AND FETAL 
CALF SERUM ON THE 
ENDOTHELIUM OF PORCINE 
AORTIC VALVES 
Endothelial integrity and funetion ma), be an important determinant for 
long-term success of allograft heart valves, To determine the optimal storage 
temperatures for preservation of long-term endothelial function in porcine 
aortic valves, different storage temperatures and times were investigated. Fresh 
valves were ither (1) stored at 4 ° C, with or without 10% fetal ealf serum 
supplement, for 1, 2, 4, 7, 14, 21, or 28 days; (2) cryopreserved for 2, 4, or 8 
weeks at -80 ° C or -170 ° C; (3) cryopreserved in long-term storage (as long 
as I year), with or without fetal calf serum, at -170 ° C. Viability of endothelial 
cells was assessed through measurement of the produetion of prostacyclin 
basal and bradykinin-stimulated conditions, during in vitro incubation of the 
valve cusps at 37 ° C. Endothelial morphologic variations in valves stored at 
4 ° C were valuated by scanning electron microscopy. With storage at 4 ° C, 
after 4 days the valves already produced signifieantly less (p < 0.05) prosta- 
cyclin than fresh preparations in both basal (0.21 - 0.04 versus 3.56 - 0.03 ng 
• m1-1 • cm -2) and stimulated conditions (4.17 - 0.36 vs 24.23 -+ 1.83). 
Morphologic hanges could not yet be distinguished with scanning electron 
microscopy at that time. When the storage period was extended, the levels of 
prostacyclin further diminished; after 14 days, prostacyclin release could no 
longer be detected. In cryopreserved valves, prostacyclin production was 
similar for as long as 2 weeks of storage ither at -80 ° C or at - 170 ° C in basal 
(2.69 -+ 0.63 vs 2.93 -+ 0.51) and stimulated (16.43 -+ 3.19 vs 16.50 - 2.57, = 
6) conditions. After 8 weeks, no prostacyclin release could be detected in valves 
stored at -80°C. After 6 months storage at -170°C, the prostacyclin 
production was signifieantly (p < 0.05) reduced compared with fresh valves; it 
then remained constant for as long as I year. The valves stored with fetal calf 
serum produced significantly (p < 0.05) less prostacyclin than did those 
without fetal calf serum. For longer cryopreserved banking, we recommend 
storing heart valves at -170 ° C instead of at -80 ° C to maintain viability of 
endothelial cells. Fetal calf serum would harm endothelial viability during 
long-term cryopreservation. (J THORAC CARD[OVASC SURG 1996;111:218-30) 
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B ecause the supply of homograft heart valves is limited and in most institutions homograft valves 
are not immediately implanted after procurement, 
storage of heart valves has become essential. At 
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present, centers that use many homograft valves and 
therefore have short delay periods for implantation 
continue to store homografts at 4°C for about a 
week (Yacoub MH, personal communication). Most 
other centers prefer cryopreservation of h mograft 
valves.1, 2 
Cryopreservation of valves includes a freezing 
procedure, a storage process, and a thawing proto- 
col. The influences of freezing program and thawing 
conditions on the endothelial viability of heart 
valves have been described previously. 3 The effects 
of both temperature and duration of storage are 
described in this article. 
In the cryopreservation of h mograft valves, con- 
troversies exist regarding how low the storage tem- 
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perature should be. Cryopreserved valves are mainly 
stored at -80  ° C in a solid carbon dioxide refrigerator 
or at -196°C in liquid nitrogen. Yankah (personal 
communication) has been storing homograft valves at 
-80  ° C for the last 5 to 7 years and intends to continue 
storing these valves for another 5 years. Other centers, 
such as CryoLife, Inc., in the United States, cryopre- 
serve valves in liquid nitrogen. This procedure is also 
included in the guidelines of Euro Transplant, Rotter- 
dam, The Netherlands. 
Storage in a refrigerator at -80  ° C in the opera- 
tion room offers practical advantages for surgeons. 
This type of storage permits inspection of the valves 
and makes it easier to determine the size of the 
homograft  valve to be used after intraoperative 
sizing of the aortic root. Preoperative chocardio- 
graphic evaluation of aortic root size often fails to 
predict the correct valve size. 
On the other hand, Lange and Hopkins 4 indicate 
that some physicochemical changes till continue at 
-130  ° C, and that even for the optimal preservation 
of the interstitial matrix the storage temperature 
should be below -130  ° C. Because self-repair by 
fibroblasts of the implanted homograft  valve could 
determine its ultimate durability in the host, and 
because the endothel ium could protect against 
thrombus formation and also prevent the loss of 
subendothelial structures, the preimplantation via- 
bility of all cells comprising the homograft  may be 
critical. We therefore compared the effect of three 
different storage temperatures, 4 ° C, -80  ° C, and 
-170  ° C, and various storage periods on prostacy- 
clin (PGI2) production in vitro as a marker of 
viability in the endothelial cells of porcine aortic 
valve cusps. We selected endothelial function for the 
assessment of homograft  cell viability after storage 
because an intact endothel ium not only helps pre- 
vent intravascular thrombosis but also can contrib- 
ute to fibroblast alimentation from the bloodstream. 
Furthermore, the endothel ium is the most vulnera- 
ble component of the aortic valve cusp and there- 
fore can be used as a sensitive indicator of overall 
cell survival. It should be noted that storing the valves 
in l iquid nitrogen at vapor-phase temperature 
( -190°C to -150 ° C) is traditionally referred to as 
storage in liquid nitrogen at - 196 ° C. In our study, we 
cryopreserved valves at -170 ° C, the temperature we 
also use in our clinical homograft valve bank. 
Material and methods 
The porcine aortic valves were stored for various peri- 
ods at 4°C in the nutrient medium or cryopreserved at
-80 ° C and -170 ° C in cryopreservation freezing medium 
after a controlled-rate freezing process. 
Valve preparation. Fresh porcine aortic valves were 
obtained from a local slaughterhouse. Hearts were re- 
moved as nearly aseptically as possible from pigs (weight 
100 to 120 kg, age 180 to 210 days) within 20 minutes after 
death. The aortic valve, along with 2 to 3 cm of ascending 
aorta and 1 to 1.5 cm of ventricular myocardium, was 
quickly excised from the heart with sterile material in a 
clean area of the slaughterhouse. The valves were placed 
carefully in ice-cold RPMI 1640 tissue medium and then 
transported to the laboratory within 40 minutes. In the 
laboratory, each valve was longitudinally separated into 
three tissue pieces. Each tissue piece consisted of the 
corresponding cusp with 3 cm adjacent aortic wall and 
some myocardium. A 7-0 Prolene suture (Ethicon, Inc., 
Somerville, N.J.) was then passed through the center of 
the free edge of the cusp to enable easy lifting from one 
solution to another. Either the distribution of the cusps 
into control and test groups was fully random or orte of 
the three cusps of a single valve served as control and the 
other two were used as test material. 
Storage procedures 
Storage at 4 ° C. The tissue piece was put into a sterile 
plastic container containing 100 ml RPMI 1640 tissue 
culture medium at 4°C with or without 10% fetal calf 
serum (FCS) and stored for various periods (1, 2, 4, 7, 14, 
21, or 28 days). Renewal of the medium was carried out 
every week until the end of the storage period for cusps 
stored longer than 7 days. 
Cryopreservation at -80  ° C and -170  ° C. Freezing 
conditions and techniques for cryopreservation have been 
described elsewhere. 3 Two hemofreeze bags (GmbH & 
Co. KG, Hechingen, Germany) filled with 100 ml medium 
were used as the packaging material. Dimethyl sulfoxide 
was added at room temperature in a concentration f 10% 
as a cryoprotective agent. The packed valves were kept at 
4°C for 20 minutes of equilibration. The valves were 
frozen in a freezing chamber with a programmable t m- 
perature controller. Temperature was monitored with a 
temperature probe. A freezing rate of -1  ° C/min at the 
site of the tissue was achieved. On termination of the 
controlled freezing program at -80 ° C, the valves were 
immediately removed from the freezing chamber and 
cryopreserved ither in a mechanical freezer at -80 ° C or 
in a liquid nitrogen tank in the vapor phase at -170 ° C. 
The valves were stored both at -80 ° C or - 170 ° C for 2, 
4, and 8 weeks. Longer storage periods of 6 months and 1 
year were also studied for valves stored at -170 ° C. For 
long-term storage, cryopreservation solutions with or 
without 10% FCS supplement were also compared. 
Estimation of PGI 2 produetion. After different storage 
periods, rapid-rate thawing and gentle dilution procedure 
of the cryoprotective agent (dimethyl sulfoxide) were used 
for all cryopreserved valves. 3Thawing was performed by 
completely immersing the frozen valves with their internal 
packaging in a large volume of water at 40 ° C. Only 2 to 3 
minutes was required to turn the ice to slush. Dimethyl 
sulfoxide concentration was decreased from 10% to 7.5%, 
5%, 2.5%, and finally 0%. Each step took only 1.5 to 2 
minutes. For all tested valves, the cusps were dissected 
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free from the valve tissue for estimation of PGI2 produc- 
tion. 
Incubation for assessment of basal and bradykinin- 
stimulated PGI 2 production has been described else- 
where. 3' » The incubation medium was kept at 37 ° C in the 
test tubes, each of which contained 2.5 ml of RPMI 1640 
supplemented with 1% (weight/volume) bovine serum 
albumin and 2% (volume/volume) 1 mol/L phosphate 
buffer (pH 7.4). After each cusp was dissected free from 
the valve tissue, it was lifted every 15 minutes from one 
test tube to another with a no-touch technique that used 
7-0 Prolene suture for 20 periods totaling 300 minutes. 
PGI 2 release into the incubation medium of each of these 
test tubes was measured by radioimmunoassay of 6-oxo- 
PGFI~, the stable metabolite of PGI2 .6 To stop continued 
PGI 2 production by shed endothelial cells, indomethacin 
(final concentration 10/xg/ml) was immediately added to 
the medium after the cusp had been removed from the 
test tube] 
Previous experiments demonstrated that during the 
incubation period, spontaneous release of PGI 2 by the 
fresh cusp follows a bell-shaped production curve. From 
270 minutes onward, the PGI 2 release, although slightly 
diminished, is no longer significantly different from the 
previous incubation period and is therefore referred to as 
basal production. This period allowed us to study PGIa 
production stimulated by a receptor-mediated mechanism 
such as bradykinin (final concentration 10 /xmol/L), s 
which was added to the incubation medium during the 270 
to 285-minute incubation period. 
Caleulation of endothelial cell surface area of the cusp. 
To calculate the amount of PGI 2 produced per square 
centimeter of the cusp surface, the ratio of the weight of 
the total dried cusp to its measured surface area was used. 
This was done after the PGI 2 estirnation by weighing a 
circular piece of the cusp, punched out by a circular knife 
(diameter 0.5 cm), of which the surface area was known 
(0.3925 cm2). 
Statistieal analysis. A paired Student's t test (5% level 
of significance) was used to compare the basal and 
stimulated PGI 2 levels because these observations were 
made in the same specimens. To compare the PGI2 
release between cusps stored according to different stor- 
age treatments, analysis of variance was used. 
Seanning eleetron rnieroseopy (SEM). The endothelial 
integrity of valves tored at 4 ° C for 2, 4, 7, 14, and 21 days 
was examined by SEM. The preparation of the tissue 
specimens and the quantification of the endothelial dam- 
age were similar to previously descriptions. 5 The valve 
cusps were fixed with 2.5% glutaraldehyde in 0.1 mol/L 
cacodylate buffer; specimens were postfixed in 1% os- 
mium tetroxide in 0.1 mol/L cacodylate buffer for 2 hours 
and then rinsed again in cacodylate buffer with 7.5% 
saccharose. Specimens were dehydrated in an ascending 
series of ethanol up to 100% strength and 100% iso- 
amylacetate, followed by critical-point drying in a Balzer 
apparatus with carbon dioxide used as transitional fluid. 
Each valve cusp was longitudinally divided into two parts. 
All surfaces were mounted on stubs with double-faced 
tape, sputter coated with a 15 nm layer of gold, and 
subsequently examined and photographed in a JEOL 
1200EX microscope equipped with scanning image device 
EM-ASIDIO (JEOL Ltd., Tokyo, Japan) operating at 40 
kV. The ventricular and aortic surfaces of each part were 
examined. At least five random fields, only from the 
center of each piece, were sampled and scored by an 
independent observer with ratings of +, + +, and + + + 
for each of the following variables: (1) overall endothelial 
coverage, (2) intercellular gaps, (3) microvilli, (4) mem- 
brane damage, (5) basal lamina, and (6) exposure of 
collagen fibrils. 
Results 
PGI 2 production 
Storage at 4 ° C 
ONE TO 21--DAY eERIOD. The PGI 2 production 
levels of valves previously stored at 4 ° C for various 
periods were compared to that of fresh valves used 
as a control. As shown in Fig. 1, PGI 2 production by 
fresh valve cusps showed a bell-shaped pattern. It 
rose to a maximum value during the 120 to 135- 
minute period of incubation and then decreased 
gradually to a steady basal evel, at which moment it 
could still be stimulated by means of a bradykinin 
receptor-mediated mechanism (Fig. 1, A). For the 
stored valves, both the spontaneous release and 
the bradykinin-stimulated production diminished as 
the duration of the storage period increased. 
After 1 day of storage (Fig. 1, B), the valves 
retained 93% _+ 4.2% of the basal release (mea- 
sured in the 15-minute period before stimulation) 
and 74% + 3.8% of the stimulated release as 
compared with fresh cusps. There was no difference 
in maximum, basal, and stimulated PGI 2 production 
levels compared with control values, although the 
bell-shaped pattern was delayed for about 40 to 60 
minutes. 
After 2 days of storage (Fig. 1, C), the basal PGI 2 
release still maintained its bell-shaped pattern, al- 
though the maximum production was significantly 
(p < 0.05) less than in fresh valves. The basal and 
stimulated PGI 2 release levels were reduced to 63% 
_+ 2.8% and 41% _+ 1.7% (p < 0.05), respectively, of
the production observed in the fresh valves. 
After 4 däys of storage (Fig. 1, D), the bell-shaped 
curve was no longer t3resent. The basal release could 
hardly be detected, and after stimulation the PGI2 
production was reduced to 17% -+ 1.5% of the 
control value. 
For as long as 7 days of storage, stimulated 
production of PGI 2 could still be observed (Fig. 1 
E). After 14 days of storage, both spontaneous and 
stimulated PGI 2 production levels were near the 
detection limit of the radioimmunoassay (Fig. 1, F). 
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Fig. 1. PGI 2 production during 300 minutes of incubation by valve cusps stored for 1 (B), 2 (C), 4 (D), 7 
(E), and 14 (F) days at 4 ° C compared with fresh valve cusps (A). The x axis refers to the time of the 
consecutive incubation periods. The y axis displays the PGI 2 content in the incubation medium within 15 
minutes of incubation. Bradykinin (B/( 10/xmol/L) was added to the medium as the agonist during the 270- to 
285-minute incubation. The bell-shaped curve in A represents spontaneous PGI 2 production by the cusps. 
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Table I. PGI2 production by porcine aortic valve cusps after storage at 4 ° C for different periods in RPMI 1640 
medium with or without FCS for different periods (in nanograms per miIliliter per square centimeter; n >- 6) 
Without FCS With FCS 
Basal Stimulated Basal Stimulated 
Control 3.56 +_ 0.30 24.23 ± 1.83" 3.56 + 0.30 24.23 +_ 1.83" 
2 days 2.50 -+ 0.25 9.96 ± 1.00" 3.48 ± 1.49 10.39 ± 1.50" 
4 days 0.42 + 0.05 4.17 ± 0.36* 0.41 _+ 0.11 4.01 + 0.063* 
7 days 0.52 _+ 0.30 4.15 +_ 1.34" 0.35 ± 0.07 2.91 ÷ 0.55* 
14 days 0.15 +- .008 0.17 ± 0.04 0.13 ± 0.003 0.11 _+ 0.07 
21 days 0.12 _+ 0.03 0.13 _+ 0.03 0.07 ± 0.01 0.09 ± 0.01 
*PGI 2 significantly (p < 0.05) increased after stimulation. 
Table II. PGI 2 production by porcine aortic valves after storage of time at 4 ° C for different periods in RPMI 
1640 medium without or with renewal of the medium (nanograms per milIiliter per square centimeter; n >- 6) 
Without renewal With renewal* 
Basal Stimulated Basal Stimulated 
Control 2.88 _+ 0.19 18.55 ± 2.07? 2.88 ± 0.19 18.55 _+ 2.07? 
7 days 0.52 ± 0.30 4.15 ± 1.347 - -  - -  
14 days 0.15 _+ 0.008 0.17 ± 0.04 0.90 ± 0.14:) 2.38 -+ 0.26?$ 
21 days 0.12 ± 0.03 0.13 _+ 0.03 0.11 _+ 0.03 1.65 + 0.36%? 
28 days - -  - -  0.08 + 0.02 0.43 ± 0.9~ 
*Medium was replaced with fresh medium every 7 days. 
?After stimulation by bradykinin, PGI 2 was significantly (p < 0.05) increased compared with basal evel. 
~:PGI 2 was significantly (p < 0.05) higher than the PGI 2 released by the group stored for the same period without renewal of medium. 
INFLUENCE OF FCS. Valves stored at 4 ° C with and 
without FCS added to the storage medium were also 
compared. Inclusion of FCS (10%) in the storage 
medium did not significantly affect he PGI 2 produc- 
tion (Table I). 
RENEWAL OF MEDIUM. Regular renewal of the 
storage medium with fresh culture medium resulted 
in a longer preservation of bradykinin-stimulated 
PGI 2 production. After 28 days of storage in which 
the storage medium was replaced with fresh me- 
dium every 7 days, bradykinin eould still signifieantly 
increase the PGI 2 production (Table II), whereas 
this was no longer possible with the cusps kept at 
4°C for 14 days in the same medium without 
renewal. Spontaneous release was less affected by 
the medium renewal and decreased as the duration 
of the storage increased. 
Cryopreservation at -80 ° C and -170 ° C 
SHORT-TERM STORAGE AT - -80  ° C AND - -170  ° C (AS 
LONO AS 8 WEEKS). Cryopreservation at either 
-80 ° C or -170 ° C for as long as 2 weeks showed 
comparable PGI 2 production levels (Fig. 2, B and 
C). Although the spontaneous release of PGI2 was 
significantly diminished, the stimulated production 
was similar to that of fresh valves (Fig. 2, A). 
Cryopreservation for 4 weeks at -80  ° C signif- 
icantly reduced both spontaneous and stimulated 
PGI 2 production as compared with fresh valves 
and valves cryopreserved at -170°C (Fig. 2, D 
and E). 
After 8 weeks of storage at -80 ° C, hardly any 
PGI 2 production (either spontaneous or stimulated) 
could be detected (Fig. 2, F). In contrast, valves 
cryopreserved at -170°C for 4 and 8 weeks still 
released PGI 2 (Fig. 2, G), and this release was 
comparable to production by the valves cryopre- 
served at -170 ° C for 2 weeks (Fig. 2, E). 
LONG-TERM STORAGE AT - -170  ° C (6 MONTHS TO 1 
YEAR). Long-term preservation i liquid nitrogen at 
vapor phase significantly (p < 0.05) reduced both 
bäsal and stimulated PGI 2 production after 6 
months compared with fresh valve cusps (Fig. 3 and 
Table III) but then remained eonstant for as long as 
1 year. When FCS was included in the cryopreser- 
ration medium, the PGI 2 production was signifi- 
cäntly (p < 0.05) redueed at 6 and 12 months of 
storage compared with the same storage period 
without FCS. 
SEM OF 4 ° C--STORED VALVES. The results of SEM 
are shown in Table IV. The morphologic alterations 
of the endothelium appeared later than the bio- 
chemical changes (decrease of PGI 2 production). 
For periods of storage at 4 ° C as long as 4 days, SEM 
could not clearly distinguish variations of the endo- 
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Fig. 2. PGI 2 production by valve cusps cryopreserved for 2 (B and C), 4 (D and E), and 8 (F and G) weeks 
at -80  ° C (B, D, and F) and -170 ° C (C, E, and G) compared with fresh valve cusps (A). The x axis refers 
to the time of the consecutive incubation periods. The y axis displays the PGI a content in the incubation 
medium within 15 minutes of incubation. Bradykinin (B/~ 10/xmol/L) was added to the medium as the 
agonist during the 270- to 285-minute period of incubation. The be]l-shaped curve in A represents 
spontaneous PGI 2 production by the cusps. 
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the consecutive incubation periods. The y axis displays the PGI2 content in the incubation medium within 15 
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285-minute peri0d of incubation. The bell-shaped curve in A represents spontaneous PGI 2production by the 
cusps. 
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Table III. PGI 2 production by porcine aortic valves after storage in liquid nitrogen at vapor phase at -170 ° C 
for as long as 1 year with or without FCS (in nanograms per milliliter per square centimeter) (n > 6). 
Without FCS With FCS 
Basal Stimulated Basal Stimulated 
Control  2.73 ± 0.26 16.55 ± 2.12 2.73 ± 0.26 16.55 _+ 2.12 
~~ yr 2.54 -+ 0.33* 9.94 ± 0 .77 ' t  1.02 _+ 0.177 6.13 ± 1.157 
1 yr 1.68 + 0.24 9.62 ± 1.7!*? 1.24 _+ 0.137 4.73 + 0.49? 
After stimulation by bradykinin, PGI2 could be significantly (p < 0.05) increased as compared to basal in all groups. 
*PGI 2 was significantly (p < 0.05) higher than PGI 2 released by the group cryopreserved for the same period with FCS. 
tPGI 2 production was s!gnificantly ess than control values. 
Table IV. Evaluation by SEM of surface morphologic haracteristics of porcine aortic valves after storage at 
4 ° C for different periods 
Storage Endothelium lntercellular Memhrane Basal Fibrils 
time coverage gaps damage lamina exposure 
Fresh + + + 0 0 0 0 
2 day +++ -+ ± 0 0 
4 days +++ ± ± 0 0 
7 days + + + + + ± 
14 days + + + + + + + 
21 days 0 0 +++ + +++ 
+++,  Strongly present; 0, absent; --, present or absent; ++, definitely present; +, present o some extent, 
thelium. Intact endothelium with numerous mi- 
crovilli covered the surface of the cusps; almost no 
subendothelial tissue could be observed, and inte> 
cellular gaps were occasionally found. Even after 7 
days of storage, most areas on the surface of valve 
cusps were still covered by endothelial cells (Fig. 4), 
Slight damage was seen in some areas (e,g. the 
shape of cells had changed, and intercellular gaps 
and retraction fibers revealing underlying basal am- 
ina could be observed ). 
The valves stored at 4 ° C for 14 days showed a 
damaged endothelial surface (Table IV). More than 
50% of the endothelial cells were destroyed (dis- 
played numerous holes in the cell membrane; Fig. 5, 
A), endothelial cells had an abn0rmal arrangement 
with an abnormal cell shape, and large intercellular 
gaps revealing basement membrane could be de- 
tected (Fig. 5, B). In some areas, endothelial cells 
were lost (Fig. 5, C). 
It was diffieult to find morphologically intact 
endothelial cells on the surface of the valves after 21 
days of storage at 4 ° C. Deendotheliafization was 
common in most areas, and underlying collagen 
fibers were often completely exposed (Table IV). A 
few scattered remnants and shriveled endothelial 
cells could be found in some fields (Fig. 6). 
Discussion 
Depending on the preservation methods used, 
cells of the homograft valve can be damaged, and 
this damage will affect valve survival in the recipient 
after implantation. When survival results of im- 
planted vatve homografts are evaluated, it is there- 
fore necessary to distinguish among viable, nonvia- 
ble, and fresh homograft valves. 9
Comparing three different storage temperatures 
(4 ° C, -80 ° C, and -170 ° C), the main advantage of
storage in the unfrozen state at 4 ° C is the avoidance 
of damage by the formation of ice crystals; the 
disadvantage however, is limitation of storage dura- 
tion. Our study demonstrates that after 24 hours of 
storage in a refrigerator at 4 ° C, endothelial cells of 
porcine aortic valve cusps retain 93% (basal) and 
74% (stimulated) PGI 2 production compared with 
fresh valves. After as long as 48 hours of storage, 
PGI 2 production was reduced to 63% (basal) and 
41% (stimulated), respectively. After 4 days at 4 ° C, 
the capacity of the endothelial eells to produce PGI 2 
had sharply declined. Yankah and associates, 1° by 
means of the dye-exclusion test, found 76%, 65%, 
and 53% viable endothelial cells after storage at 
4°C for 2, 20, and 30 hours, respectively. Clearly, 
endothelium loses its viability within a short time 
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Fig. 4. SEM photograph ofvalves tored at 4 ° C in RPMI 1640 medium for 7 days. Most of the surface of 
valve cusp was covered by morphologically normal endothelium (original magnification × 800). 
when stored at 4 q C. Our study on storage at 4°C 
also indicated that  functional alteration of endo- 
thelial cells (PGI 2 production) occurred earlier than 
pronounced morphologic hanges. After 1 week of 
storage at 4 ° C, SEM of the valves still revealed a 
semiconfluent layer of endothelial cells even though 
their biochemical function had already decreased 
significantly. 
Viability of fibroblasts of heart valves stored at 
4°C has been previously studied. Yankah and 
Hetzer, 1° with the dye-exclusion technique, showed 
that 80% of the fibroblasts were viable after 30 
hours of storage at 4 ° C. Mochtar and colleagues n 
stored canine valves at 4°C and, by means of the 
technique of autoradiograph protein sy thesis, that 
fibroblasts were only viable for 1 week. They could 
not reproduce the results of high viability after 
storage at 4°C for more than 1 week reported by 
A1-Janabi and coworkers. 12 The observation by 
Mochtar and colleagues 11on fibroblast viability are 
similar to our findings on endothelial cell PGI 2 
production (Table II), and both indicate a rapid 
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Fig. 5° SEM photographs of valves stored at 4°C in RPMI 1640 for 14 days. A, Many holes in the 
membrane of the endothelial cells (original magnification x600). B, Intercellular gaps and exposure of 
basement membrane could be detected (original magnification ×3000). C, Some endothelial cells lost (×600). 
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Fig. 6. SEM photograph of valves tored at 4 ° C in RPMI 1640 for 21 days. Most areas howed a complete 
exposure of fibers. Some remnant endothelial cells could be found, but they are shrivelled (Original 
magnification ×800). 
deterioration of the viability of the cells within 1 
week of storage at 4 ° C. 
The main advantage of cryopreservation is that 
long-term storage can range from months to years. 
Preservation periods ranging from 10 years 13 to 
32,000 years t4 have been suggested. Such long peri- 
ods can only be achieved with the temperature limits 
below the glass transition point of the freezing 
solution, which is approximately -130 ° C. 15 In this 
way, changes in the structure of frozen tissue can be 
avoided because chemical and physical processes 
are almost completely inhibited. The results of our 
study confirmed that a temperature below -130°C 
is necessary for long-term preservation of the viabil- 
ity of the endothelial cells of heart valves. For as 
long as 2 weeks, the viability of the endothelial cells 
was similar whether stored at -80  ° C or at -170 ° C 
(Fig. 2). When valves are intended to be stored for 
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such short periods, we recommend storage at 
-80°C because this temperature offers practical 
advantages over storage at -170 ° C, which requires 
special tank filling with liquid nitrogen. 
On the other hand, ice recrystallization has been 
detected at temperatures a low as - 130 ° C 14' is  and 
was found to be accelerated at temperatures higher 
than -130°C.  16 This could explain why after 4 
weeks of storage at -80  ° C the PGI 2 production by 
the endothelium of cryopreserved valves signifi- 
cantly decreased in our experiments. In contrast, 
after 8 weeks of storage at - 170 ° C, stimulated PGI 2 
production of the cryopreserved valves was not 
significantly reduced compared with fresh valves. 
FCS is commonly added to tissue culture medium as 
protein supplement 17 because it is considered to 
induce RNA and DNA synthesis. 18 For this reason, 
FCS is widely used in cryopreservation media for a 
variety of tissues and cells including human tis- 
sues. 19-22 It has also been used to enhance viability 
of preserved aortic homograft valves. 1°'23 On the 
other hand, FCS is a potent heterologous antigen. 24 
In a previous study, we found that FCS was not 
required for cryopreservation of porcine aortic 
valves. 3 In th~s study, we demonstrated the negative 
influence of FCS (loss of endothelial function during 
long-term cryopreservation). The results showed 
lower PGI 2 release after bradykinin stimulation in 
valves stored at - 170 ° for 6 months when FCS was 
used as a supplement in the medium (Table III). 
Although we cannot explain this observation, we can 
state that, contrary to what has been usually recom- 
mended, the addition of FCS to the cryopreserva- 
tion medium is not advisable for maintaining the 
functional integrity of the endothelial layer. 
From our results, we conclude the following: (1) 
Endotheliäl viability of aortic valve cusps is retained 
until 4 days of storage at 4°C but is remarkably 
decreased thereafter. Morphologic alterations ap- 
peared later. Viability of entire valve storage at 4 ° C 
should be assessed by measuring viability of endo- 
thelial cells because implanting a homograft valve 
with an apparently morphologically normal endo- 
thelial structure but with reduced or absent function 
might mean that the collagen-laying self-repair func- 
tion of the underlying fibroblasts could also be 
disturbed. (2)  There was no difference in PGI 2 
production after 14 days of cryopreservation at 
either -80  ° C or -170 ° C. Although preservation at 
-80  ° C is a more convenient technique for storage, 
liquid nitrogen vapor-phase storage at temperatures 
below -130 ° C is required for long- term preserva- 
tion of endothelial function. (3) Not only is FCS 
unnecessary for short-term storage, it may actually 
be deleterious to the functional integrity of the 
endothelial cells. 
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